Literature DB >> 31023454

Resistant Hypertension: Diagnosis and Management.

Nagalakshmi Nagarajan1, Diana Jalal2.   

Abstract

Resistant hypertension is defined as high blood pressure requiring 3 or more medications for adequate control or controlled blood pressure requiring 4 or more medications. Considering the growing prevalence of hypertension and the strong link with cardiovascular disease, it is vital to understand the causes and treatment of resistant hypertension. This review article starts with an overview of the prevalence and little-known pathophysiology of resistant hypertension. Afterward, we discuss the evaluation and management of suspected secondary resistant hypertension in 2 broad categories: pseudoresistant hypertension and true resistant hypertension. Strategies for the identification and management of pseudoresistant hypertension are addressed. In addition, causes of true resistant hypertension, such as obstructive sleep apnea, primary aldosteronism, and renal artery stenosis, are examined along with their respective treatments. Finally, treatment of resistant hypertension is reviewed including pharmacologic treatments and novel procedural interventions for resistant hypertension. Overall, the review hopes to provide practitioners with a cohesive approach for the diagnosis and treatment of resistant hypertension. Published by Elsevier Inc.

Entities:  

Keywords:  Diagnosis; Hypertension; Resistant; Secondary; Treatment

Mesh:

Substances:

Year:  2019        PMID: 31023454     DOI: 10.1053/j.ackd.2019.03.002

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  3 in total

Review 1.  Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study.

Authors:  A Bédard; X Basagaña; J M Anto; J Garcia-Aymerich; P Devillier; S Arnavielhe; A Bedbrook; G L Onorato; W Czarlewski; R Murray; R Almeida; J A Fonseca; J Correia da Sousa; E Costa; M Morais-Almeida; A Todo-Bom; L Cecchi; G De Feo; M Illario; E Menditto; R Monti; C Stellato; M T Ventura; I Annesi-Maesano; I Bosse; J F Fontaine; N Pham-Thi; M Thibaudon; P Schmid-Grendelmeier; F Spertini; N H Chavannes; W J Fokkens; S Reitsma; R Dubakiene; R Emuzyte; V Kvedariene; A Valiulis; P Kuna; B Samolinski; L Klimek; R Mösges; O Pfaar; S Shamai; R E Roller-Wirnsberger; P V Tomazic; D Ryan; A Sheikh; T Haahtela; S Toppila-Salmi; E Valovirta; V Cardona; J Mullol; A Valero; M Makris; N G Papadopoulos; E P Prokopakis; F Psarros; C Bachert; P W Hellings; B Pugin; C Bindslev-Jensen; E Eller; I Kull; E Melén; M Wickman; G De Vries; M van Eerd; I Agache; I J Ansotegui; S Bosnic-Anticevich; A A Cruz; T Casale; J C Ivancevich; D E Larenas-Linnemann; M Sofiev; D Wallace; S Waserman; A Yorgancioglu; D Laune; J Bousquet
Journal:  Clin Transl Allergy       Date:  2020-12-09       Impact factor: 5.871

Review 2.  Health-Promoting and Therapeutic Attributes of Milk-Derived Bioactive Peptides.

Authors:  Mrinal Samtiya; Sweta Samtiya; Prarabdh C Badgujar; Anil Kumar Puniya; Tejpal Dhewa; Rotimi E Aluko
Journal:  Nutrients       Date:  2022-07-22       Impact factor: 6.706

3.  Consensus paper on the evaluation and treatment of resistant hypertension by the Turkish Society of Cardiology.

Authors:  Asife Sahinarslan; Emine Gazi; Meryem Aktoz; Cigdem Ozkan; Gülay Ulusal Okyay; Ozgul Ucar Elalmis; Erdal Belen; Reviewers Atila Bitigen; Ulver Derici; Neslihan Bascil Tutuncu; Aylin Yildirir
Journal:  Anatol J Cardiol       Date:  2020-09       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.